CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis

202127 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Multiple Sclerosis and Related Disorders

Volume 57, pp. 103448-103448

Field-Weighted Citation Impact: 1.56